AllSight
Companies · TDOC · Services-Offices & Clinics Of Doctors Of Medicine · Exec change · Aug 13, 2026

Teladoc loses a longtime director—but the filing flags no internal rift

Director retirementnew
Retirement effective September 30, 2026, after serving since 2014
Teladoc Health, Inc. (TDOC) — what happened, in plain English, and what it means versus what the market expected.

This is a governance update, not an operating event. David B. Snow, Jr. notified Teladoc on August 10, 2026 that he intends to retire from the board effective September 30, 2026 after serving as a director since 2014. (Item 5.02)

The filing gives no indication of internal conflict. Snow cited personal reasons and explicitly said the retirement was not related to any disagreement with Teladoc. (Item 5.02)

There is no measurable gap versus business expectations to assess. The 8-K contains no change to management, strategy, financial outlook, capital allocation, or operations, so the appropriate read is a neutral director departure rather than a beat or miss.

Read the original 8-K on SEC EDGAR ↗
More from Teladoc Health, Inc. (TDOC)
Sep 25, 2026Teladoc CLO resigns for “good reason,” with internal successor lined upAug 31, 2026Teladoc names Michael Grasher CFO, but severance terms—not operations—drive the filingAll TDOC filings, decoded →
Related companies in Services-Offices & Clinics Of Doctors Of Medicine
Latest across the market
ACNAccenture earnings beat as Q4 revenue clears guidance, but FY27 growth stays measuredROPRoper Technologies adds NTT DATA CEO to board, but brings no operating changeIIPRIIPR loan increase funds Alewife buildout, but locks in 14% debtGLUEMonte Rosa GFORCE-1 results clear safety bar, but ASCVD Phase 2 moves to 2027SMASmartStop dividend holds at $1.60 annualized as October payout repeats patternHBNCHorizon Bancorp schedules Q3 earnings, offering no fresh business readBrowse all companies, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.
Analysis by AllSight · Editorial standards & method · Contact